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Abstract. 
 
Formation of intracellular transport interme-
diates and selection of cargo molecules are mediated by 
protein coats associated with the cytosolic face of mem-
branes. Here, we describe a novel family of ubiquitous 
coat proteins termed GGAs, which includes three 
members in humans and two in yeast. GGAs have a 
modular structure consisting of a VHS domain, a region 
of homology termed GAT, a linker segment, and a re-
gion with homology to the ear domain of 
 
g
 
-adaptins. 
Immunoﬂuorescence microscopy showed colocaliza-
tion of GGAs with Golgi markers, whereas immuno-
electron microscopy of GGA3 revealed its presence on 
coated vesicles and buds in the area of the TGN. Treat-
ment with brefeldin A or overexpression of dominant-
negative ADP ribosylation factor 1 (ARF1) caused dis-
sociation of GGAs from membranes. The GAT region 
of GGA3 was found to: target a reporter protein to the 
Golgi complex; induce dissociation from membranes of 
ARF-regulated coats such as AP-1, AP-3, AP-4, and 
COPI upon overexpression; and interact with activated 
ARF1. Disruption of both 
 
GGA
 
 genes in yeast resulted 
in impaired trafﬁcking of carboxypeptidase Y to the 
vacuole. These observations suggest that GGAs are 
components of ARF-regulated coats that mediate pro-
tein trafﬁcking at the TGN. 
Key words: trans-Golgi network • ADP ribosylation 
factor • coats • adaptins • VHS
 
Introduction
 
Protein trafficking at various stages of the endocytic and
secretory pathways is mediated by vesicular intermediates
that carry cargo molecules between different membrane-
bound compartments. Both the formation of these inter-
mediates and cargo selection depend upon the function of
a set of protein coats that are recruited from the cytosol to
membranes (reviewed by Mellman, 1996; Rothman and
Wieland, 1996; Schekman and Orci, 1996; Kirchhausen et
al., 1997). Some coats contain as their key constituents ei-
ther one of four heterotetrameric adaptor protein (AP)
 
1
 
complexes (subunit compositions indicated in parentheses):
AP-1 (
 
g
 
-
 
b
 
1-
 
m
 
1-
 
s
 
1); AP-2 (
 
a
 
-
 
b
 
2-
 
m
 
2-
 
s
 
2); AP-3 (
 
d
 
-
 
b
 
3-
 
m
 
3-
 
s
 
3); or AP-4 (
 
e
 
-
 
b
 
4-
 
m
 
4-
 
s
 
4; reviewed by Hirst and Robin-
son, 1998; Bonifacino and Dell’Angelica, 1999; Kirch-
hausen, 1999). AP-2 has the shape of a “head” with two
protruding “ears” (Heuser and Keen, 1988); the other
three complexes are thought to have a similar structure. A
more distantly related coat protein complex, known as
coatomer or COPI (
 
a
 
-
 
b
 
-
 
b9
 
-
 
g
 
-
 
d
 
-
 
e
 
-
 
z
 
), has been shown to
play a role in ER–Golgi and endocytic trafficking path-
ways (reviewed by Lippincott-Schwartz et al., 1998; Wie-
land and Harter, 1999).
Recruitment of AP-1, AP-3, AP-4, and COPI, but not
AP-2, from the cytosol to membranes is regulated by
members of the ADP-ribosylation factor (ARF) family of
small GTP-binding proteins (Donaldson et al., 1992a,b;
Robinson and Kreis, 1992; Palmer et al., 1993; Stamnes
and Rothman, 1993; Traub et al., 1993; Faundez et al.,
1998; Ooi et al., 1998; Dell’Angelica et al., 1999a; Hirst et
al., 1999). ARF1 is the most abundant member of the fam-
ily and also the most active for recruitment of COPI and
AP-3 to membranes (Liang and Kornfeld, 1997; Ooi et al.,
1998); other ARFs (ARF2-5) may also be able to regulate
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coat recruitment. In contrast, ARF6 does not seem to play
a role in coat recruitment (Peters et al., 1995; Ooi et al.,
1998), but rather in remodeling the plasma membrane and
underlying actin cytoskeleton (Radhakrishna et al., 1996).
Like other GTP-binding proteins, ARFs cycle between
GDP-bound (inactive) and GTP-bound (active) forms,
which are localized to the cytosol and membranes, respec-
tively (reviewed by Boman and Kahn, 1995; Moss and
Vaughan, 1998). Membrane-bound ARF1-GTP has been
shown to be the species that promotes recruitment of
COPI onto membranes (Donaldson et al., 1992a), either
directly by interacting with the coat proteins themselves
(Zhao et al., 1997), or indirectly through local modifica-
tion of the lipid composition of the membranes (Ktistakis
et al., 1996).
Although it is now well established that AP complexes,
COPI and ARFs play key roles in the molecular mecha-
nisms responsible for vesicle formation and cargo selec-
tion, it is also clear that they constitute only part of the
coat-mediated trafficking machinery. Here we report the
identification of a novel family of adaptor-related proteins
referred to as GGAs (for Golgi-localized, 
 
g
 
 ear-containing
ARF-binding proteins), which are ubiquitously expressed
in mammalian and yeast cells. The three mammalian and
two yeast GGA proteins have a modular structure consist-
ing of (in NH
 
2
 
- to COOH-terminal order): a VHS domain
(Lohi and Lehto, 1998); a region of homology termed
GAT; a linker segment; and a domain with homology to
the ear of the 
 
g
 
1-adaptin subunit of AP-1 and the related
 
g
 
2-adaptin. The mammalian GGAs are components of
coats that are mainly associated with the TGN in an ARF-
dependent manner. The GAT region mediates both tar-
geting to the Golgi complex and interaction with activated
ARF1. Overexpression of constructs having the GAT re-
gion causes dissociation of ARF1-regulated coats from
membranes. Finally, disruption of genes encoding the two
yeast GGA homologues impairs sorting of carboxypepti-
dase Y (CPY) to the vacuole, consistent with a role of
these proteins in biosynthetic protein transport. All of
these observations suggest that GGAs are components
of the molecular machinery that mediates protein traffick-
ing at the TGN.
 
Materials and Methods
 
Nucleic Acid Manipulations
 
A cDNA segment comprising codon 5 to the stop codon of the long form
of human GGA1 was PCR-amplified from a human heart cDNA library,
using primers based on partial genomic DNA sequences from GenBank/
EMBL/DDBJ (accession numbers AL035496.6 and Z83844). The 5
 
9
 
primer included an additional sequence to place a Myc epitope at the pro-
tein’s NH
 
2
 
 terminus. The first codons and a short 5
 
9
 
 untranslated region
were obtained from the same cDNA library by 5
 
9
 
RACE-PCR. The com-
plete open reading frame (ORF) of human GGA2 was PCR-amplified
from a human pancreas cDNA library using primers that were designed
based on the sequence of the A-735G6.4 gene (GenBank/EMBL/DDBJ
accession number AC002400). The ORFs encoding long and short forms
of GGA3 were isolated by a combination of PCR and 5
 
9
 
RACE-PCR, us-
ing for primer design the sequence of the DNA clone KIAA0154 (Gen-
Bank/EMBL/DDBJ accession number D63876). All the above PCR prod-
ucts were cloned into the pCR 3.1 vector (Invitrogen) and sequenced.
The construct GST-GGA2
 
GAE
 
 was generated by PCR amplification of
codons 424–613 of human GGA2 and subsequent cloning into the
BamHI–NotI sites of the pGEX-5X-1 vector (Pharmacia Biotech). The
 
constructs GST-GGA3
 
VHS
 
, GST-GGA3
 
VHS-GAT
 
, and GST-GGA3
 
GAE
 
were obtained by PCR amplification of codons 1–146, 1–313, and 494–723
of the human GGA3 long isoform, respectively, followed by cloning into
the EcoRI–NotI sites of the pGEX-5X-1 vector. GFP-fusion constructs,
comprising different regions of the GGA3 long isoform, were prepared by
PCR and subsequent cloning into the EcoRI–SalI sites of the pEGFP-C2-
MCS vector (Clontech), as follows: GFP-VHS (residues 1–146); GFP-
VHS-GAT (residues 1–313); and GFP-GAT (residues 147–313). The in-
serts of these three constructs were subcloned into the pGAD424 vector
to generate analogous two-hybrid constructs. Additional constructs pre-
pared in the pGAD424 two-hybrid vector by PCR and in-frame cloning
were as follows: residues 1–352 of GGA3 long isoform (GGA3
 
VHS-GAT-39
 
;
EcoRI–SalI); residues 494–723 of GGA3 long isoform (GGA3
 
GAE
 
;
EcoRI–BglII); residues 5–247 of human GGA1 (GGA1
 
VHS-GAT
 
; EcoRI–
SalI); and residues 1–330 of human GGA2 (GGA2
 
VHS-GAT
 
; EcoRI–SalI).
The insert of the two-hybrid construct GGA3
 
GAE
 
 was subcloned into the
EcoRI–BamHI sites of the pEGFP-C2-MCS vector to generate the GFP-
GAE construct. The two-hybrid ARF1/Q71L construct was engineered by
PCR from the HA-ARF1-Q71L mammalian expression plasmid (Ooi et al.,
1998) and cloned in-frame (without the HA sequence) into the EcoRI–
XhoI sites of the pGBT9 vector (Clontech). The corresponding two-
hybrid ARF1/T31N plasmid and the GST-
 
g
 
2-adaptin
 
GAE
 
 construct were
kindly provided by Chean Eng Ooi (National Institutes of Health, Be-
thesda, MD).
 
Antibodies
 
Polyclonal antibodies to human GGA2 and GGA3 were raised in rabbits
using as immunogens purified GST-GGA2
 
GAE
 
 and GST-GGA3
 
GAE
 
, re-
spectively. Both antibodies were affinity-purified on columns containing
their corresponding immunogens coupled to Affi-Gel 15 (BioRad). Rab-
bit polyclonal antibody to human TGN46 was a gift from Vas Ponnam-
balam (University of Dundee, UK). Antibodies to yeast CPY were gifts of
Tom Stevens (University of Oregon, Eugene, OR) and Carol Woolford (Car-
negie Mellon University, Pittsburgh, PA). The following antibodies were
purchased from the providers indicated in parentheses: HA.11 mAb to the
HA epitope and 9E10 mAb to the Myc epitope (Berkeley Antibody Co.);
mAb to 58-K Golgi protein (Sigma Chemical Co.); rabbit anti–
 
b
 
-COP and
1D9 monoclonal anti-ARF (Affinity Bioreagents); rabbit anti-Rab4
(Santa Cruz); mouse monoclonal anti-dynamin I (Transduction Laborato-
ries); sheep anti–human TGN46 (Serotec); and rabbit anti–sheep IgG
(Jackson ImmunoResearch Laboratories). The sources of the remaining
antibodies have been indicated in previous reports (Dell’Angelica et al.,
1999a,b).
 
Cell Culture and General Biochemical Procedures
 
The sources and culture conditions of the human cell lines HeLa, M1, H4,
Jurkat, Caco-2, MEG-01, and MNT-1 have been described previously
(Dell’Angelica et al., 2000). Metabolic labeling of cells in culture with
[
 
35
 
S]methionine, preparation of Triton X-100 and detergent-free extracts,
salt extraction of postnuclear membranes, ultracentrifugation on sucrose
gradients, and immunoprecipitation–recapture were carried out as de-
scribed previously (Dell’Angelica et al., 1997). Recombinant GST-fusion
proteins were purified by using glutathione-Sepharose 4B beads (Pharma-
cia Biotech).
 
Transfection and Immunofluorescence
 
Transfection of HeLa cells was performed by using FuGENE-6 (Roche
Molecular Biochemicals). Immunofluorescence microscopy analysis was
carried out as described (Dell’Angelica et al., 1999a). Images were ac-
quired on Zeiss LSM 410 or LSM 510 confocal microscopes. The lack of
antibody cross-reactivity or optical cross-over on two-color fluorescence
experiments was corroborated using appropriate controls done in parallel.
 
Immunoelectron Microscopy
 
Immunoelectron microscopy of ultrathin frozen sections of HeLa cells
transfected with a GGA3 construct was performed essentially as de-
scribed (Slot and Geuze, 1983). In brief, cells were fixed in 4% formalde-
hyde, 0.1 M phosphate buffer (pH 7.4) for 2 h at room temperature,
scraped, and embedded in 10% gelatin. Gelatin blocks were incubated for
16 h in 2.3 M sucrose at 4
 
8
 
C, and then frozen in liquid nitrogen. Ultrathin
frozen sections were made with a cryoultramicrotome (Reichert Ultracut
S) and transferred to grids using sucrose/methyl cellulose droplets. Sec- 
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tions were treated with 1% fish skin gelatin and 0.15 M glycine before in-
cubation at room temperature with rabbit antibody to GGA3. Bound an-
tibody was detected by incubation with protein A conjugated to 5-nm (for
double-labeling) or 10-nm (for single-labeling) gold particles (Utrecht
University, The Netherlands). For double-labeling experiments, sections
were subsequently incubated with sheep anti–human TGN46, rabbit anti–
sheep IgG, and then 10-nm protein A-gold. Labeled sections were exam-
ined with a Philips CM 10 transmission electron microscope.
 
Yeast Two-Hybrid Assays
 
The 
 
Saccharomyces cerevisiae
 
 strain HF7c was transformed by the lithium
acetate procedure as described in the instructions for the MATCH-
MAKER two-hybrid kit (Clontech). For colony growth assays, two colo-
nies of each HF7c transformant were resuspended in water to 0.1 O.D
 
600
 
/ml,
then 5 
 
m
 
l were applied on plates lacking leucine and tryptophan, or leu-
cine, tryptophan and histidine, and allowed to grow at 30
 
8
 
C for 3–4 d. 
 
b
 
-galac-
tosidase assays of HF7c transformants were done by using the colony-lift
filter assay (Clontech).
 
In Vitro ARF-binding Assays
 
Purified recombinant ARF1/Q71L (kindly provided by Paul Randazzo,
NIH) was activated by incubating for 1 h at 32
 
8
 
C in binding buffer (25 mM
Hepes, pH 7.4, 0.1 M NaCl, 1 mM dithiothreitol, 1 mM EDTA, 1 mM
MgCl
 
2
 
, 0.5 g/liter BSA, 0.1% w/v Triton X-100) containing 0.1 mM gua-
nosine 5
 
9
 
-O-(3-thiotriphosphate) (GTP
 
g
 
S). A control incubation in buffer
lacking GTP
 
g
 
S was carried out in parallel. Bovine brain cytosol (9 mg/ml)
was similarly incubated in binding buffer containing protease inhibitors
[1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 10 mg/liter aprotinin, 2
mg/liter leupeptin, 1 mg/liter pepstatin A], in the presence or absence of
0.1 mM GTP
 
g
 
S. Following the incubation period, samples were centri-
fuged for 5 min at 100 
 
g
 
 and further incubated with glutathione-Sepharose
4B beads containing 20 
 
m
 
g of GST-fusion proteins, either at room temper-
ature for 30 min (for recombinant ARF1/Q71L) or at 4
 
8
 
C for 1 h (for bo-
vine brain cytosol). Beads were subsequently washed twice with ice-cold
binding buffer and once with ice-cold binding buffer lacking Triton X-100.
Bound proteins were analyzed by immunoblotting.
 
Disruption of Yeast GGA1 and GGA2 Genes and
Pulse–Chase Analysis of CPY Processing
 
DNA fragments comprising 
 
z
 
480 bp upstream of the start codon to nucle-
otide number 570 of the yeast 
 
GGA1
 
 ORF (YDR358w) and 
 
z
 
200 bp up-
stream of the start codon to the stop codon of the yeast 
 
GGA2
 
 ORF
(YHR108w) were amplified by PCR from yeast genomic DNA and cloned
into pCR2.1 (Invitrogen). To create the
 
 GGA1
 
 disruption cassette, an 823-
bp fragment containing the 
 
TRP1
 
 gene and its promoter was amplified
from plasmid yDp-W (Berben et al., 1991) using 5
 
9
 
 and 3
 
9
 
 primers engi-
neered to contain SacII restriction sites. This fragment was cloned into the
SacII site (
 
GGA1
 
 ORF nucleotide 46) of the 
 
GGA1
 
 genomic clone. To
create the 
 
GGA2
 
 disruption cassette, a 1.15-kb fragment containing the
 
HIS3
 
 gene and its promoter was amplified from plasmid yDp-H (Berben
et al., 1991) using 5
 
9
 
 and 3
 
9
 
 primers engineered to contain BstEII and ClaI
restriction sites, respectively. The 
 
GGA2
 
 genomic clone was digested with
BstEII and ClaI to remove 1,024 bp of the 
 
GGA2
 
 ORF and allow insertion
of the 
 
HIS3
 
 marker. Fragments consisting of the 
 
GGA1
 
 genomic sequence
containing the 
 
TRP1
 
 marker and the 
 
GGA2
 
 genomic sequence containing
the 
 
HIS3
 
 marker were then transformed individually and in combination
into wild-type haploid yeast strain SEY6210 (Herman and Emr, 1990).
Homologous recombinants were selected on minimal media lacking the
appropriate amino acid(s). Putative disruption strains were then screened
by PCR and verified by Southern blot analysis. Pulse–chase analysis of
yeast strains with [
 
35
 
S]methionine (Mullins et al., 1995), immunoprecipita-
tion with CPY antiserum (Hampton and Rine, 1994) and secretion of
CPY (Roberts et al., 1991) were performed as described.
 
Online Supplemental Materials
 
The online version of this article includes figures that accompany the
information presented here and is available at http://www.jcb.org/cgi/
content/full/149/1/81/DC1. 
 
Supplemental Figure 1.  
 
Multiple sequence alignments of VHS (A),
GAT (B), and GAE (C) regions of human GGAs and the corresponding
segments of related human proteins. 
 
g
 
1, 
 
g
 
1-adaptin; 
 
g
 
2, 
 
g
 
2-adaptin. Gen-
 
Bank/EMBL/DDBJ accession numbers are indicated in the legend to Fig.
1. The positions of the segments within the proteins’ primary structures
are indicated by residue numbers next to the sequences. Highlighted let-
ters represent residues conserved in at least four (A) or three (B and C) of
the proteins.
 
Supplemental Figure 2.  
 
Intracellular localization of Myc-GGA1 and
GGA2 analyzed by indirect immunofluorescence microscopy of trans-
fected cells. HeLa cells transfected with either Myc-GGA1 (A–C, G–I) or
both GGA2 and HA-tagged TGN38 (D–F) were fixed, permeabilized,
and stained as follows: A–C, mouse antibody to the Myc epitope and rab-
bit antibody to TGN46 followed by Alexa-488–conjugated donkey anti–
mouse IgG (A and C, green channel) and Cy3-conjugated donkey anti–
rabbit IgG (B and C, red channel); D–F, rabbit antibody to GGA2 and
mouse antibody to the HA epitope followed by Cy3-conjugated donkey
anti-rabbit IgG (D and F, red channel) and Alexa-488–conjugated donkey
anti-mouse IgG (E and F, green channel); and G–I, mouse antibody to the
Myc epitope and rabbit antibody to GGA3 followed by Alexa-488–conju-
gated donkey anti–mouse IgG (G and I, green channel) and Cy3-conju-
gated donkey anti–rabbit IgG (H and I, red channel). Stained cells were
examined by confocal fluorescence microscopy. Bar, 10 
 
m
 
m.
 
Results
 
Identification and Domain Organization of
GGA Proteins
 
Homology searches of sequences derived from both ge-
nomic and EST sequencing projects revealed the existence
of at least three novel human genes encoding proteins with
similarity to the ear domain of the 
 
g
 
1-adaptin subunit of
AP-1. The complete ORFs of these proteins, herein referred
to as GGA1 (GenBank/EMBL/DDBJ accession number
AF218584), GGA2 (GenBank/EMBL/DDBJ accession
number AC002400) and GGA3 (GenBank/EMBL/DDBJ
accession numbers AF219138 and AF219139 for long and
short alternatively spliced forms, respectively), were iso-
lated from human cDNA libraries using a combination of
PCR and 5
 
9
 
 RACE. Complete or partial sequences of
GGA2 and GGA3 (short isoform) recently have been
published by others as a result of large-scale DNA se-
quencing projects (Nagase et al., 1995; Kikuno et al., 1999;
Loftus et al., 1999). The GGAs have also been indepen-
dently identified by Boman et al. (2000) and Hirst et al.
(2000). Northern blot analyses have shown that the three
human GGA mRNAs are expressed in all human tissues
examined (our unpublished observations; see also Nagase
et al., 1995; Kikuno et al., 1999). Subsequent database
searches revealed the occurrence of GGA-related proteins
in other eukaryotic organisms. In particular, two ORFs from
 
S
 
.
 
 cerevisiae
 
, YDR358w and YHR108w, were deemed to
encode the yeast counterparts of human GGAs; we refer
to these proteins as yeast Gga1p and Gga2p, respectively.
The three human and two yeast GGAs were found to
share a similar domain organization consisting of four dis-
tinct regions (Fig. 1; and Supplemental Figure 1, http://
www.jcb.org/cgi/content/full/149/1/81/DC1). The first re-
gion, comprising 
 
z
 
140 residues proximal to the GGAs’
NH
 
2
 
 termini, displays significant homology to the VHS
domain, a protein module previously found in the verte-
brate proteins TOM1 (i.e., target of myb 1; not to be
confused with mitochondrial outer membrane proteins),
TOM1L1, Hrs, Hrs-2, and STAM1, as well as in yeast
Vps27p (Lohi and Lehto, 1998, and references therein).
The second region, comprising the next 
 
z
 
160 residues, is
highly homologous among the human GGAs and contains 
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an 
 
z
 
85 residue segment with low but significant homology
to human TOM1 and TOM1L1. We refer to this region as
“GAT” to denote the occurrence of homology among the
GGA and TOM1 proteins. The GAT region has a high
propensity to fold into coiled coil structures. The third re-
gion is much less conserved among the GGAs; it is of vari-
able size, rich in prolines and serines, and predicted to
adopt a random coil conformation. Finally, the 
 
z
 
125 resi-
dues proximal to the GGAs COOH termini display signif-
icant homology to the ear domains of the 
 
g
 
1-adaptin
subunit of mammalian AP-1 and of the closely related
 
g
 
2-adaptin protein (Robinson, 1990; Lewin et al., 1998;
Takatsu et al., 1998). We refer to this region as GAE, for
 
g
 
-adaptin ear homology domain.
 
Biochemical Characterization of Endogenous GGA2 
and GGA3 in Human Cells
 
To study the biochemical properties of the human GGAs,
we raised polyclonal antibodies to GST-fusion proteins
bearing the corresponding GAE domains. Antibodies to
GGA2 and GGA3 allowed us to identify the endogenous
proteins in HeLa cells, by using an immunoprecipitation–
recapture procedure (Fig. 2 A). The electrophoretic mo-
bility of the protein recognized by the anti-GGA2 antibody
corresponded to a polypeptide of 
 
z
 
70 kD, a molecular
mass that was in close agreement with that predicted for
human GGA2 (67.2 kD). The apparent molecular mass of
the protein isolated with the antibody to GGA3 (
 
z
 
90 kD)
was larger than that expected for the long isoform of
GGA3 (78.3 kD). However, specificity controls convinced
us that the 
 
z
 
90-kD protein corresponded to GGA3. First,
the protein was isolated only when the anti-GGA3 anti-
body was used in both the first and second immunoprecip-
itation steps (Fig. 2 A). Second, recognition of this protein
by the anti-GGA3 antibody was completely inhibited by
excess GST-GGA3
 
GAE
 
, but not by similar amounts of
GST or GST-GGA2
 
GAE
 
 (data not shown). Finally, the
anti-GGA3 antibody did not crossreact with endogenous
GGA2, the 
 
g
 
1-adaptin subunit of AP-1, or overexpressed
Myc-GGA1 (data not shown). Both GGA2 and GGA3
were expressed in a wide variety of human cell lines (Fig. 2
B), in agreement with the results of Northern blot analyses.
Subcellular fractionation of metabolically labeled HeLa
cells yielded most of endogenous GGA2 and GGA3 in a
cytosolic fraction. A small (
 
,
 
10%) fraction, however, was
associated with a postnuclear membrane pellet (Fig. 2
C). The membrane-associated forms of both GGA2 and
GGA3 could be extracted with 0.2 M sodium carbonate,
pH 11 (data not shown). These results suggested that
GGA2 and GGA3 exist as both soluble and peripherally
membrane-bound forms.
To estimate the sizes of the soluble forms of GGA2 and
GGA3, a cytosolic extract was fractionated by ultracentrif-
ugation on a 5–20% sucrose gradient, and the resulting
fractions were analyzed by immunoprecipitation–recap-
ture (Fig. 2 D). Both GGA2 and GGA3 were recovered
from fractions corresponding to a sedimentation coeffi-
cient of 
 
z3.5 S. This value was significantly smaller than
those obtained for heterotetrameric AP complexes (e.g.,
10 S for AP-4; Dell’Angelica et al., 1999a), thus suggest-
ing that GGA2 and GGA3 are not components of AP-
like complexes. Rather, the calculated sedimentation co-
efficients of GGA2 and GGA3 are more compatible
with these proteins existing as monomers or dimers with an
asymmetric shape. GGA2 did not coprecipitate with GGA3
(Fig. 2 A) or GGA1 (Hirst et al., 2000), suggesting that they
do not form stable dimers with one another.
Localization of GGAs to the Golgi Complex and 
Peripheral Cytoplasmic Structures
To examine the intracellular localization of the human
GGA proteins, we initially performed indirect immuno-
fluorescence microscopy analysis on fixed-permeabilized
HeLa cells using the rabbit polyclonal antibodies to the
Figure 1. Schematic repre-
sentation of GGAs and re-
lated proteins. Total num-
bers of amino acid residues
of each protein are noted on
the right. Specific domains or
regions of homology are
color coded. Black lines de-
note variable regions with no
significant homology. Acces-
sion numbers are as follows:
human GGA1, AF218584;
human GGA2 (A-735G6.4),
AC002400; human GGA3
(long isoform), AF219138;
yeast Gga1p (YDR358w),
NC_001136; yeast Gga2p
(YHR108w), NC_001140;
human TOM1, AJ006973;
human TOM1-L1, AJ010071;
human Hrs, D84064; yeast
Vps27p, U24218; human
STAM1, U43899; human g1-
adaptin, AB015317; human
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GAE domains of GGA2 and GGA3. Only the antibody to
GGA3 was found to detect the endogenous antigen under
these conditions (Fig. 3). This antibody gave punctate
staining of a juxtanuclear structure resembling the Golgi
complex (Fig. 3, A, D, G, J, M, and P). Staining was judged
to be specific, as it could be inhibited by addition of a
GST-GGA3GAE fusion protein (Fig. 3 B) but not by GST-
GGA2GAE (Fig. 3 C), GST-g2-adaptinGAE (data not shown)
or GST (Fig. 3 A).
The juxtanuclear structure stained by the anti-GGA3
antibody displayed partial colocalization with the TGN
markers, TGN38 (Fig. 3, D–F) and furin (Fig. 3, G–I), and,
to a lesser extent, with the cis-medial Golgi marker, 58-K
protein (Fig. 3, J–L). We also observed partial colocaliza-
tion of GGA3 with AP-1 in the juxtanuclear area of the
cell, although the patterns of staining were not coincident
(Fig. 3, M–O). There was little colocalization of GGA3
with AP-3 in the area of the Golgi complex (Fig. 3, P–R,
left inset). However, we could observe faint staining for
GGA3 in peripheral cytoplasmic foci, some of which did
colocalize with AP-3 (Fig. 3, P–R, right inset), as well as
with AP-1 (data not shown). We did not detect any colo-
calization of GGA3 with the plasma membrane-associated
AP-2 complex (data not shown). Taken together, these
observations suggest that GGA3 is mainly associated with
the TGN, with an additional population of molecules lo-
calized to a peripheral cytoplasmic compartment.
Myc-epitope-tagged GGA1 (Myc-GGA1) or untagged
GGA2 expressed at moderate levels by transfection into
HeLa cells also exhibited good colocalization with TGN
markers (Supplemental Figure 2, http://www.jcb.org/cgi/
content/full/149/1/81/DC1). In addition, Myc-GGA1 colo-
calized with endogenous GGA3 (Supplemental Figure 2,
http://www.jcb.org/cgi/content/full/149/1/81/DC1). Similar
observations were made for endogenous GGA1 and
epitope-tagged GGA2 by Hirst et al. (2000). These obser-
vations suggest that, like GGA3, GGA1 and GGA2 are
predominantly localized to the TGN.
Association of GGA3 with Coated Membranes in the 
Area of the TGN
The intracellular localization of human GGA proteins was
further investigated by immunoelectron microscopy on ul-
trathin HeLa cell sections. As labeling of endogenous
GGA3 yielded a very low signal, we expressed higher lev-
els of the untagged protein by transfection. Staining of
cells expressing moderate levels of the transgene with anti-
GGA3 antibody revealed specific labeling in an area of tu-
bules and vesicles adjacent to the Golgi stack (Fig. 4 A). A
more detailed inspection of structures stained for GGA3
revealed that the gold particles were associated with bud-
ding membrane profiles covered with an electron-dense
coat (Fig. 4 B). The region labeled for GGA3 was identi-
fied as the TGN by double-labeling with anti-GGA3 and
anti-TGN46 antibodies (Fig. 4 C). Similar analyses per-
formed on HeLa cells transfected with Myc-GGA1 also
showed concentration of label in the area of the TGN, al-
though significant labeling of the Golgi stack was also ob-
served (data not shown).
Regulation of GGA Localization by ARFs
Since ARF1 regulates recruitment of various protein coats
to membranes, it was of interest to investigate whether this
was also the case for GGAs. To this end, we first examined
the effect of treating HeLa cells with brefeldin A (BFA), a
pharmacological inhibitor of ARF1 guanine nucleotide ex-
change activity (Donaldson et al., 1992b). We observed
that treatment with 2 mg/ml BFA for 5 min was sufficient
to effect complete disappearance of endogenous GGA3
staining from both the juxtanuclear area and peripheral
foci (Fig. 5, A and B). At this early time of treatment, the
Golgi cisternae and TGN had not yet disrupted, suggesting
that the disappearance of GGA3 staining was not due to
redistribution of the Golgi complex to the ER or endo-
Figure 2. Biochemical characterization of endogenous GGA2
and GGA3. A, HeLa cells were metabolically labeled with
[35S]methionine for z22 h and lysed in the presence of Triton X-100
(Dell’Angelica et al., 1997). The cleared extract was immuno-
precipitated using antibodies to GGA2 or GGA3, and the result-
ing precipitates were subjected to a second immunoprecipitation
step using antibodies to GGA2, GGA3, or two irrelevant pro-
teins. The final immunoprecipitates were analyzed by 4–20%
SDS-PAGE and fluorography. B, The indicated human cell lines
were labeled with [35S]methionine and subjected to immunopre-
cipitation–recapture, using antibodies to GGA2 (top) or GGA3
(bottom). C, A detergent-free extract (Dell’Angelica et al., 1997)
of metabolically labeled HeLa cells was centrifuged first at 600 g
for 5 min to remove nuclei and then at 120,000 g for 90 min to ob-
tain cytosolic (C) and post-nuclear membrane (M) fractions.
Both fractions were subjected to immunoprecipitation–recapture
with antibodies to GGA2 or GGA3. D, A cytosolic fraction ob-
tained as in C was loaded onto a 4–20% sucrose gradient and
centrifuged in an SW-41 Beckman rotor at 39,000 rpm for 17 h at
48C. Collected fractions were analyzed for GGA2 and GGA3 by
immunoprecipitation–recapture. The positions of protein stan-
dards and the AP-4 complex in the gradient are indicated by ar-
rows and an arrowhead, respectively.The Journal of Cell Biology, Volume 149, 2000 86
somes, but rather to dissociation into the cytosol. Removal
of BFA from the culture medium resulted in reassociation
of GGA3 with both the juxtanuclear and peripheral struc-
tures (Fig. 5 C), indicating that the effects of the drug were
reversible. Similar effects of BFA were observed for Myc-
GGA1 and GGA2 expressed by transfection into HeLa
cells (data not shown).
Another test for the involvement of ARF1 in recruit-
ment of protein coats to membranes is the expression of
dominant-negative ARF1 mutants. Overexpression of such
dominant-negative mutants renders endogenous ARF1 in-
active by sequestering guanine nucleotide exchange fac-
tors required for their activation (Peyroche et al., 1999);
this in turn elicits dissociation of protein coats similar to
that caused by BFA (Dascher and Balch, 1994; Peters et
al., 1995; Ooi et al., 1998). Overexpression of dominant-
negative ARF6, on the other hand, has no effects on pro-
tein coats (Peters et al., 1995; Ooi et al., 1998). We ob-
served that overexpression of dominant-negative ARF1/
T31N in HeLa cells resulted in disappearance of endoge-
nous GGA3 from its juxtanuclear location (Fig. 5, D and
E). A dominant-negative ARF5/T31N mutant had a simi-
Figure 3. Intracellular lo-
calization of endogenous
GGA3 analyzed by indirect
immunofluorescence micros-
copy. A–C, HeLa cells were
fixed, permeabilized, and in-
cubated with rabbit antibody
to the GAE domain of
GGA3 in the presence of
excess GST (A), GST-
GGA3GAE (B), or GST-
GGA2GAE (C) proteins. The
bound antibody was revealed
by staining with Cy3-conju-
gated donkey anti–rabbit
IgG. D–R, HeLa cells trans-
fected with HA-tagged
TGN38 (D–F) or HA-tagged
furin constructs (G–I), or un-
transfected HeLa cells (J–R)
were fixed, permeabilized,
and double-labeled with
rabbit antibody to GGA3
followed by Cy3-conjugated
donkey anti-rabbit IgG (D,
G, J, M, and P; red channel),
and mouse antibodies to the
HA epitope (E and H),
the 58K-Golgi protein (K),
the  g1-adaptin subunit of
AP-1 (N,100/3), or the AP-3
complex (Q, mouse poly-
clonal antibody to AP-3), fol-
lowed by Alexa-488–conju-
gated donkey anti–mouse
IgG (green channel). Stained
cells were examined by con-
focal fluorescence micros-
copy. The third picture on
each row in D–R was gener-
ated by merging of the im-
ages in the red and green
channels; yellow indicates
overlapping localization. In-
sets in D–O and the left inset
in P–R show twofold magni-
fied views of the Golgi region
of the cells. The right inset in
P–R shows a twofold magni-
fied view of the peripheral
cytoplasm. Bar, 10 mm.Dell’Angelica et al. Novel Adaptor-related Proteins 87
lar, albeit less dramatic, effect (data not shown), consistent
with the reduced potency of this construct in the regula-
tion of other protein coats (Ooi et al., 1998). Overexpres-
sion of a dominant-negative ARF6/T27N construct, on the
other hand, had no effect on GGA3 association with the
juxtanuclear structure (Fig. 5, F and G). Taken together,
the effects of BFA and the ARF1 dominant-negative mu-
tant suggest that association of GGA with membranes is
regulated by ARF1.
Targeting to the TGN Mediated by the GAT Region
We next sought to identify the region of GGA3 responsi-
ble for targeting this protein to the TGN. Expression con-
structs were made by fusing the green fluorescent protein
(GFP) to the VHS domain alone, the VHS domain plus
GAT region, the GAT region alone, or the GAE domain,
as shown in Fig. 6. The constructs were expressed by trans-
fection into HeLa cells, and their intrinsic fluorescence
used to compare their localization in moderately express-
ing cells relative to endogenous TGN46. We observed that
the VHS (Fig. 6, A–C) or GAE (Fig. 6, J–L) domain con-
structs were cytosolic, whereas the VHS plus GAT (Fig. 6,
D–F) or GAT region (Fig. 6, G–I) constructs colocalized
with TGN46. This experiment thus demonstrated that the
GAT region alone (z160 amino acids) is sufficient for tar-
geting a reporter protein to the TGN. Treatment with
BFA also caused rapid dissociation of GFP-GAT from the
TGN (Fig. 6, M–O).
Dissociation of ARF-regulated Coats Induced by 
Overexpression of the GAT Region
In the course of the experiments described above, we no-
ticed that a fraction of the transiently transfected cells ex-
pressing the highest levels of GFP-GAT or GFP-VHS-
GAT (typically 5–10%) accumulated these proteins in the
cytosol, probably due to saturation of binding sites at the
Golgi complex (Fig. 7, A, C, E, and I). Strikingly, these
cells exhibited dissociation of AP-1, AP-3, AP-4, and COPI,
as well as endogenous GGA3, from their corresponding in-
tracellular membranes (Fig. 7, A–F, and data not shown).
In contrast, the localization of AP-2 was not affected
by overexpression of any of these constructs (data not
shown). Overexpression of GFP-VHS or GFP-GAE con-
structs did not affect the distribution of the protein coats
mentioned above (see for example Fig. 7, G and H). Thus,
the effects of overexpressing the GAT region (or proteins
having this domain) are reminiscent of manipulations that
inactivate endogenous ARF1, which suggests a possible
functional relationship of the GAT region to ARF1.
We also observed that high expression levels of GFP-
GAT (Fig. 7, I and J), GFP-VHS-GAT, but not GFP-VHS
(data not shown), caused a redistribution of TGN46 to a
more diffuse peripheral location. The nature of this loca-
tion was not established.
Interaction of the GAT Region with Activated ARF1
The fact that overexpression of proteins having the GAT
Figure 4. Ultrastructural
analysis of GGA3 localiza-
tion by immunoelectron mi-
croscopy. Ultrathin frozen
sections of HeLa cells trans-
fected with a GGA3 con-
struct were immunolabeled
for GGA3 (10-nm gold; A
and B) or for GGA3 (5-nm
gold) and TGN46 (10-nm
gold; C), as described in Ma-
terials and Methods. N, nu-
cleus; G, Golgi stack; ER, en-
doplasmic reticulum; PM,
plasma membrane. Bars: (A)
0.2 mm; (B and C) 0.1 mm.The Journal of Cell Biology, Volume 149, 2000 88
region caused redistribution specifically of coats regulated
by ARF1 prompted us to test whether the GAT region or
other portions of the GGA proteins interact directly with
ARF1. To this end, we used the yeast two-hybrid system,
by cotransforming a suitable yeast strain with various com-
binations of ARF1 and GGA-domain plasmid constructs.
Interactions were assayed by complementation of histi-
dine auxotrophy in the absence or presence of 3-amino-
1,2,4-triazole (3AT) and by expression of b-galactosidase
activity (Fig. 8 A). We observed that GGA3-derived VHS-
GAT and GAT constructs, but not VHS or GAE con-
structs, interacted with the constitutively activated ARF1
mutant, ARF1/Q71L (Fig. 8 A). Interactions were strong,
as growth could still be observed in the presence of 10 mM
3AT (Fig. 8 A), and b-galactosidase activity developed af-
ter just 30 min. VHS-GAT constructs derived from GGA1
and GGA2 also interacted with ARF1/Q71L (data not
shown). In contrast, the inactive ARF1 mutant, ARF1/
T31N, failed to interact with VHS-GAT or GAT con-
structs from GGA3 (Fig. 8 A), GGA1, or GGA2 (data not
shown) in both the growth and b-galactosidase assays. The
yeast two-hybrid assays were corroborated using in vitro
binding assays in which recombinant ARF1/Q71L, or na-
tive ARF from bovine brain cytosol, were tested for inter-
action with GST-fusion proteins comprising different re-
gions of GGA3 (Fig. 8 B). The GST-fusion protein having
the VHS-GAT segment, but not those having the VHS or
GAE regions, bound both recombinant ARF1/Q71L and
bovine brain ARF upon activation with GTPgS (a nonhy-
drolyzable GTP analogue). In contrast, we did not observe
binding in samples that had been mock-activated in the
absence of GTPgS (Fig. 8 B). Furthermore, neither of two
other GTP-binding proteins, Rab4 and dynamin I, inter-
acted with the VHS-GAT segment (Fig. 8 B). Taken to-
gether, the above experiments demonstrated that the
GAT region is capable of interacting with activated ARF1.
Figure 5. Effects of BFA and
dominant-negative ARF mu-
tants on the localization of
endogenous GGA3 ana-
lyzed by immunofluores-
cence microscopy. A–C, Un-
treated HeLa cells (A),
HeLa cells treated for 5 min
at 378C with 2 mg/ml BFA
(B), or HeLa cells treated for
5 min with 2 mg/ml BFA fol-
lowed by removal of the drug
for 1 h at 378C (C) were
fixed, permeabilized, and in-
cubated with rabbit antibody
to GGA3, followed by Cy3-
conjugated donkey anti–rab-
bit IgG. D–G, HeLa cells
were transfected with HA-
tagged ARF1/T31N (D and
E) or HA-tagged ARF6/
T27N (F and G). Cells were
fixed, permeabilized, and
double-labeled with rabbit
antibody to GGA3 followed
by Cy3-conjugated donkey
anti–rabbit IgG (E and G),
and mouse antibody to the
HA epitope followed by
Alexa-488–conjugated don-
key anti–mouse IgG (D and
F). Stained cells were exam-
ined by confocal fluorescence
microscopy. Bars, 10 mm.Dell’Angelica et al. Novel Adaptor-related Proteins 89
Disruption of Both Yeast GGA Genes Impairs CPY 
Sorting to the Vacuole
The predominant localization of the human GGAs to the
TGN pointed to their possible role in sorting at this or-
ganelle. To test this hypothesis, the yeast GGA genes
were disrupted by homologous recombination. Both single
(gga1D and gga2D), as well as the double (gga1D/gga2D),
mutant strains were viable and grew at rates indistinguish-
able from that of the wild-type parental strain at 23, 30,
and 378C (data not shown). To investigate a possible sort-
ing defect in the mutant strains, we examined the traffick-
ing of the vacuolar enzyme, CPY.
Immunoblot analysis revealed that the gga1D and gga2D
strains contained mostly mature, 61-kD CPY, similar to
the parental wild-type strain (Fig. 9 A). The gga1D/gga2D
strain, on the other hand, displayed a reduced amount of
mature CPY and increased amounts of larger CPY spe-
cies, particularly the Golgi precursor form (p2; Fig. 9 A).
Figure 6. Intracellular local-
ization of GFP fusion pro-
teins containing different
regions of GGA3. Top,
Schematic representation of
the GFP fusion proteins used
in these experiments, includ-
ing a summary of their local-
izations. A–L, Fluorescence
microscopy of cells express-
ing GFP fusion proteins and
immunostained for TGN46.
HeLa cells were transfected
with plasmids encoding GFP-
VHS (A–C), GFP-VHS-
GAT (D–F), GFP-GAT (G–
I), or GFP-GAE (J–L).
Transfected cells were fixed,
permeabilized, and immuno-
stained with a rabbit anti-
body to TGN46 followed by
Cy3-conjugated donkey anti–
rabbit IgG. Cells were exam-
ined by confocal fluores-
cence microscopy. A, D, G,
and J, GFP fluorescence
(green); B, E, H, and K,
TGN46 (red). M–O, Live
cells expressing GFP-GAT
were imaged at 378C by con-
focal fluorescence micros-
copy immediately before
(M), and 56 s (N) and 100 s
(O) after addition of 10 mg/
ml BFA. Bar, 10 mm.The Journal of Cell Biology, Volume 149, 2000 90
Pulse–chase and immunoprecipitation analyses showed
that all of the CPY was processed from the p1 and p2 pre-
cursors to the mature form within 15 min of chase in the
wild-type strain (Fig. 9 B). In contrast, only z50% of the
CPY precursors were processed to the mature form, even
after 30 min of chase in the gga1D/gga2D strain, with the
rest accumulating as the Golgi precursor form p2 (Fig. 9
B). These analyses thus demonstrated that mutation of
both  GGA genes results in delayed processing of p2 to ma-
ture CPY (Fig. 9 B). In addition, a colony blotting assay
revealed significant secretion of immunoreactive CPY in
the gga1D/gga2D strain (Fig. 9 C). Thus, the delayed pro-
cessing of CPY to the mature, vacuolar form was likely
due to impaired transport to the vacuole and partial mis-
sorting to the periplasmic space. 
Discussion
Assembly of protein coats involved in vesicle formation
and cargo selection is a complex process requiring the con-
certed action of many structural and regulatory proteins.
These proteins establish dynamic networks of low affinity
interactions that cooperatively lead to the assembly of sta-
ble coats on membranes. Most proteins involved in coat
assembly have a modular structure, which enables them to
interact simultaneously with multiple other proteins and/or
membrane lipids. The three human and two yeast mem-
bers of the GGA family reported fit this description, as
they are composed of at least four distinct regions referred
to as VHS, GAT, linker and GAE. Despite the homology
of this latter region to the ear domain of the g1-adaptin
subunit of AP-1, the GGAs represent a novel type of
adaptor-related proteins that are not part of AP com-
plexes.
The VHS domain has been previously identified in a
group of proteins thought to play roles in protein traffick-
ing and/or signal transduction (Lohi and Lehto, 1998, and
references therein). Although some of these proteins have
been localized to endocytic vesicles (Piper et al., 1995;
Asao et al., 1997; Komada et al., 1997; Lohi et al., 1998), it
is currently unclear whether the VHS domain can function
as a localization determinant. In this regard, our experi-
ments show that a GFP fusion protein containing the VHS
domain of GGA3 is cytosolic, suggesting that this domain
is insufficient to confer association with intracellular mem-
branes.
Immediately adjacent to the COOH terminus of the
VHS domain of the GGA proteins is a region that we call
GAT. The three human GGA proteins are highly homolo-
gous in the GAT region, and also exhibit significant, albeit
more limited, homology to analogous regions in the two
yeast Ggaps and the human TOM1 and TOM1L1 proteins
(Seroussi et al., 1999). We report here that, unlike the
VHS domain, the GAT region of GGA3 alone is intrinsi-
cally capable of targeting proteins to the Golgi complex
and mediating interactions with activated ARF1. It is cur-
rently unclear whether these two activities map to the
same sites on the GAT region and whether the analogous
regions of TOM1 and TOM1L1 have these activities. This
combination of a membrane targeting function and an
ability to interact with a small GTP-binding protein, how-
ever, is a characteristic of other protein modules, such as
Figure 7. Effects of overexpression of GFP-GAT or GFP-VHS
on protein coats and TGN46 analyzed by fluorescence micros-
copy. HeLa cells were transfected with plasmids encoding GFP
fused to either the GAT (A–F, I and J) or VHS (G and H) re-
gions of GGA3. Cells were fixed, permeabilized, and incubated
with the 100/3 antibody to the g1-adaptin subunit of AP-1 (B and
H), the b3C1 antibody to the b3A subunit of AP-3 (D), or rabbit
antibodies to the b-COP subunit of COPI (F) or TGN46 (J).
Bound antibodies were revealed by staining with either Cy3-con-
jugated donkey anti–mouse IgG (B and H) or Cy3-conjugated
donkey anti–rabbit IgG (D, F, and J). A, C, E, and I, GFP-GAT;
G, GFP-VHS. Arrows point to cells that overexpress the GFP
constructs. Bar, 10 mm.Dell’Angelica et al. Novel Adaptor-related Proteins 91
the FYVE (Simonsen et al., 1998) and GRIP (Barr, 1999)
domains.
The intervening segment between the GAT region and
GAE domain of both human GGAs and yeast Ggaps is
rich in proline and serine residues and has a high probabil-
ity of random coils. These features suggest that this region
may act as a flexible hinge that links the VHS-GAT and
GAE domains of the proteins. The linker region of human
GGA2 contains the sequence LIDLE, and that of yeast
Gga1p the sequences LIDFD and LLDFD, all of which
conform to the motif L(L,I)(D,E,N)(L,F)(D,E) implicated
in binding to the clathrin terminal domain (Dell’Angelica
et al., 1998). Imperfect variants of this motif are also
present in the other GGA proteins. Whether any of these
motifs are actually capable of mediating interactions of
GGAs with clathrin will have to be investigated experi-
mentally.
By analogy with the ear domains of the a/g/d/e AP sub-
units, the GAE domain of GGAs could interact with regu-
latory molecules. Indeed, GST pulldown assays have
shown that the GAE domains of GGAs and g-adaptins
bind a number of cytosolic proteins, some of which may be
involved in coated vesicle formation (Hirst et al., 2000).
Our immunoelectron microscopy and subcellular frac-
tionation analyses suggest that GGAs are components of
protein coats that cycle between the cytosol and mem-
branes. Moreover, the dissociation of GGA3 or GFP-
GAT from membranes induced by treatment with BFA or
expression of a dominant-negative ARF1, as well as the di-
rect interaction of the GAT domain with activated ARF1,
suggest that recruitment of GGAs to membranes is regu-
lated by the ARF GTP/GDP cycle. Since the GGAs do
not contain domains that are characteristic of guanine nu-
cleotide exchange factors or GTPase activating proteins,
they are most likely to function as ARF effectors. This
places the GGAs in the same category as other ARF1-reg-
ulated protein coats, such as COPI, AP-1, AP-3, and AP-4.
It remains to be established, however, whether GGAs are
themselves structural components of novel coats, or regu-
lators of the assembly of other coats.
Immunofluorescence and immunoelectron microscopy
analyses suggest that GGA3 is mainly associated with the
TGN and may therefore be involved in trafficking events
at this organelle. We have also noticed faint punctate
staining for GGA3 in the peripheral cytoplasm and partial
colocalization of GGA3 with AP-1 and AP-3 on immuno-
fluorescence microscopy; this suggests the existence of an
additional pool of GGA3 associated with peripheral (per-
haps endosomal) structures. The GFP-GAT chimera also
shows good colocalization with TGN markers. However,
its pattern of staining is continuous rather than punctate.
A possible explanation for this observation is that GFP-
GAT is properly targeted to the TGN, but lacks the ability
to concentrate in coated vesicles and buds.
Overexpression of GFP-GAT, but not GFP fusion pro-
teins having other domains of GGA3, causes dissociation of
ARF1-regulated coats from membranes. This correlates well
with the ability of the GAT region to interact with activated
ARF1. This could mean that GGAs play roles in the ARF1-
mediated deposition of protein coats onto membranes. A
more likely explanation, however, is that overexpression of
GFP-GAT either sequesters activated ARF1 or blocks a
common effector binding site within the ARF1 molecule,
thus preventing recruitment of other coats to membranes.
The existence of two GGA homologues in yeast has al-
lowed us to assess the function of these proteins in vivo.
Figure 8. Binding of acti-
vated ARF1 to the GAT do-
main of GGA3. A, Two-hybrid
assays. Yeast transformants
expressing the combinations
of constructs indicated in the
figure were spotted onto
plates lacking leucine and
tryptophan, with or without
histidine (1His and 2His,
respectively), and in the ab-
sence or presence of 10 mM
3AT. Filter b-galactosidase
(b-gal) assays were per-
formed on cells grown in the
presence of histidine. Notice
the growth in the absence
of histidine and the positive
b-galactosidase activity of
transformants expressing the
activated ARF1 mutant
(Q71L) and the GGA3 con-
structs that include the GAT
domain. B, In vitro binding
assays. Bovine brain cytosol and recombinant ARF1/Q71L were either treated with 0.1 mM GTPgS (1GTPgS) or mock-treated (–GTPgS),
and subsequently incubated with glutathione-Sepharose beads containing GST or GST-fusion proteins comprising the VHS, VHS-
GAT, or GAE domains of human GGA3. Bound proteins were analyzed by immunoblotting, using the 1D9 antibody to ARF or anti-
bodies to the Rab4 and dynamin I GTP-binding proteins. Notice the GTPgS-dependent binding of bovine brain ARF, and of recombi-
nant ARF1/Q71L, to the GST-fusion protein bearing the VHS-GAT segment, but not the VHS or GAE regions, of GGA3.The Journal of Cell Biology, Volume 149, 2000 92
Double-mutants of genes encoding these proteins displayed
delayed processing of CPY from a Golgi to a vacuolar form.
In addition, we observed secretion of immunoreactive CPY
into the periplasmic space. These observations are consis-
tent with impairment of transport to the vacuole, a pheno-
type characteristic of vps mutants (Horazdovsky et al., 1995;
Conibear and Stevens, 1998). Mutation of either of the two
yeast GGA genes individually had little or no effect on CPY
processing and secretion, suggesting that both gene prod-
ucts fulfill redundant functions. Perhaps this is also the ex-
planation for the existence of three GGAs in humans.
In conclusion, our studies of human and yeast GGAs
suggest that these proteins are components of coats associ-
ated mainly with the TGN in an ARF1-dependent man-
ner, and involved in protein trafficking at this organelle.
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